We did not incorporate other potentially crucial prognostic factors, such as systemic inflammatory biomarkers (e.g., high-sensitivity C-reactive protein), detailed history of medication use (in particular, the dosage and adherence to statin therapy), or prior history of stroke or transient ischemic attack. This evidence concerns the gene CRP and Stroke.